Growth Metrics

IDEAYA Biosciences (IDYA) Accumulated Depreciation & Amortization (2019 - 2025)

IDEAYA Biosciences' Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 12.5% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.7 million, up 12.5%, while the annual FY2025 figure was $2.7 million, 12.5% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $2.7 million at IDEAYA Biosciences, up from $700000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.7 million in Q4 2025 and bottomed at $400000.0 in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $1.2 million (2023), against an average of $1.3 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization surged 333.33% in 2021 before it tumbled 61.11% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.7 million in 2021, then rose by 23.53% to $2.1 million in 2022, then grew by 19.05% to $2.5 million in 2023, then decreased by 4.0% to $2.4 million in 2024, then grew by 12.5% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Accumulated Depreciation & Amortization are $2.7 million (Q4 2025), $700000.0 (Q3 2025), and $700000.0 (Q2 2025).